-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $268 at Needham
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $260 at Guggenheim
-
-
-
-
-
-
-
Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
B.Riley Starts Axsome Therapeutics (AXSM) at Buy
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Misses Q2 EPS by 36c, offers guidance
-
1,232,653 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


